Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients

Table 4

Reduction of IOP from baseline of PGAs in OAG/OHT.

Author	Year	BIM (n)	TRA (n)	LAT (n)	TAF (n)
Konstas et al. [22]	2007	9.3 ± 3.4 (124)	N. A	8.3 ± 3.6 (125)	N. A
Mizoguch et al. [26]	2012	N. A	2.2 ± 2.2 (90)	N. A	2.3 ± 2.3 (90)
Kuwayama and Komemushi [24]	2008	N. A	N. A	6.2 ± 2.5 (51)	6.6 ± 2.5 (46)
Traverso et al. [25]	2010	N. A	N. A	8.6 ± 3.0 (18)	9.5 ± 3.1 (18)
Ge et al. [8]	2015	N. A	N. A	9.2 ± 4.1 (105)	9.8 ± 4.0 (91)

BIM: bimatoprost, TRA: travoprost, LAT: latanoprost, TAF: tafluprost.